Morningstar Acciones

医渡科技有限公司 02158 StarRatingValueLabel_4Mr. Lee Davidson, Head of Quantitative Research

Último Precio
3,38
Cambio del día
-0,02|-0,59%

a 19/04/2024
16:08:34 HKT | HKD  Minimum 15 Minutes Delay.

Bid/OffersRango del DíaVolumen90d Ave VolCapitalización
3,35 - 3,383,28 - 3,393.542.0002.795.6543,59Bil
Último Cierre52 Week RangeP/BeneficioDividendo %ISIN
3,403,28 - 7,29--KYG9845C1069

Cotización Yidu Tech Inc

Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
Cuentas Financieras
202120222023
More...
Cuenta de Resultados
Ingresos867,041.237,20804,70
Operating Income-415,95-682,06-600,65
Resultado Neto-3.700,29-762,32-627,97
Beneficio Básico por Acción-7,24-0,80-0,63
Num Medio Acciones diluidas en circulación511958995
Balance
Activo Corriente5.150,154.552,204.511,42
Activos no corrientes99,75170,61400,09
Total Activo 5.249,894.722,814.911,51
Pasivo corriente414,58611,58671,01
Total Pasivo---
Total Equity4.729,573.989,804.082,36
Flujo de Caja
Flujo de caja operativo-331,68-614,68-357,01
Inversiones de Capital-19,05-68,80-21,18
Flujo de Caja Libre-350,73-683,48-378,19

En millones, excepto "EPS básico". Currency is CNY.

Perfil de la compañía

Yidu Tech offers healthcare Big Data. It is an AI cloud-based firm providing solutions and tools to aid in more informed decisions to drive better efficiency in clients' strategies. Its clients are hospitals, pharmaceutical, biotech and medical device firms, research institutions, insurance companies, patients, and regulators. It three business segments are: Big Data platform and solutions, which partners with hospitals and policymakers to drive better efficiency; life sciences solutions, which enables better probability of clinical trial success with less drug development time and cost; and health management solutions, which helps with patient management. The Big Data platform accounted for 33% of revenue, life science solutions 30%, and health management solutions 27%, in fiscal 2022.

Sector

Atención sanitaria

Industria

Servicios de Información Sanitaria

Estilo de acciones

Peq-Valor

Fin Ejercicio Fiscal

marzo

Empleados

944
Datos destacados
More...
Precio/Beneficio 12 m-
Precio/Valor contable0,81
Price/Sales TTM-
Crec Ingresos (media 3 a)12,97
Crec BPA (media 3 a)-
Margen operativo-74,64
Margen neto-78,04
ROE 12 m-15,56
Deuda/Fondos propios0,00
Dividendos
AntLatest
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0,000,00
Mr. Lee Davidson, Head of Quantitative Research
The conduct of Morningstar's analysts is governed by Morningstar's Code of Ethics, Securities Trading and Disclosure Policy, and Investment Research Integrity Policy. For information regarding conflicts of interest, please click here.
Fair Value is derived from a detailed projection of a company’s future cash flows. Analysts create custom industry and company assumptions to feed income statement, balance sheet, and capital investment assumptions into a proprietary discounted cash flow modeling template. Scenario analysis, in-depth competitive advantage analysis, and a variety of other analytical tools are used to augment the discounted cash flow process. Combining analysts’ financial forecasts with the firm’s economic moat helps us assess how long returns on invested capital are likely to exceed the firm’s cost of capital. Because we are modeling free cash flow to the firm—representing cash available to provide a return to all capital providers—we discount future cash flows using the weighted average of the costs of equity, debt, and preferred stock (and any other funding sources), using expected future proportionate long-term, market-value weights. If our base-case assumptions are true the market price will converge on our fair value estimate over time, generally within three years. Investments in securities are subject to market and other risks. Past performance of a security may or may not be sustained in future and is no indication of future performance. For detail information about the Qualitative Fair Value, please click here.
© Copyright 2024 Morningstar, Inc. Reservados todos los derechos.

Términos de uso        Política Privacidad        Cookie Settings        Aviso Legal